Evidence map›Paper›PMID 39696809›Full record

ArticleMicrobial biotechnology2024

Exploration of In Situ Extraction for Enhanced Triterpenoid Production by Saccharomyces cerevisiae.

Mariam Dianat, Sarah Straaten, Aldo Maritato, Daniel Wibberg, Tobias Busche, Lars M Blank, Birgitta E Ebert

Abstract read
In one paragraph

Article in Microbial biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mariam DianatInstitute of Applied Microbiology (iAMB), Aachen Biology and Biotechnology (ABBt), RWTH Aachen University, Aachen, Germany.ORCID 0000-0001-6430-6146
Sarah StraatenInstitute of Applied Microbiology (iAMB), Aachen Biology and Biotechnology (ABBt), RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-5555-5834
Aldo MaritatoInstitute of Applied Microbiology (iAMB), Aachen Biology and Biotechnology (ABBt), RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-9147-0467
Daniel WibbergCenter for Biotechnology (CeBiTec), Bielefeld University Institute of Bio, and Geosciences - Computational Metagenomics (IBG-5), Forschungszentrum Jülich GmbH - Branch Office Bielefeld University, Forschungszentrum Jülich GmbH, Bielefeld, Germany.ORCID 0000-0002-1331-4311
Tobias BuscheCenter for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.ORCID 0000-0001-9211-8927
Lars M BlankInstitute of Applied Microbiology (iAMB), Aachen Biology and Biotechnology (ABBt), RWTH Aachen University, Aachen, Germany.ORCID 0000-0003-0961-4976
Birgitta E EbertAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Queensland, Australia.ORCID 0000-0001-9425-7509

Funding

Bundesministerium für Bildung und Forschung 031B0356B
6 · The paper itself

Abstract

Plant-derived triterpenoids are in high demand due to their valuable applications in cosmetic, nutraceutical, and pharmaceutical industries. To meet this demand, microbial production of triterpenoids is being developed for large-scale production. However, a prominent limitation of microbial synthesis is the intracellular accumulation, requiring cell disruption during downstream processing. Destroying the whole-cell catalyst drives up production costs and limits productivity and product yield per cell. Here, in situ product extraction of triterpenoids into a second organic phase was researched to address this limitation. An organic solvent screening identified water-immiscible isopropyl myristate as a suitable in situ extractant, enabling extraction of up to 90% of total triterpenoids from engineered Saccharomyces cerevisiae. Combining isopropyl myristate and β-cyclodextrins improved extraction efficiency. In a first configuration, repeated batch fermentation with sequential product extraction and cell recycling resulted in 1.8 times higher production than a reference fermentation without in situ product extraction. In the second configuration, yeast cells were in contact with the second organic phase throughout a fed-batch fermentation to continuously extract triterpenoids. This resulted in 90% product extraction and an extended production phase. Further improvement of triterpenoid production was not achieved due to microbial host limitations uncovered through omics analyses.

Indexed as

FermentationSaccharomyces cerevisiaeTriterpenesChemical FractionationMetabolic EngineeringTriterpenesbetulinic acidbiocompatible solventin situ extractionmetabolic engineeringorganic solventplant natural productsprocess developmentsecondary metabolitestriterpenoidsyeast

Identifiers

PMID39696809
PMCPMC11655670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.